Patents by Inventor Andrew E. Parker

Andrew E. Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human checkpoint kinase, hCDS1, compositions and methods
    Patent number: 7414020
    Abstract: The invention provides for a novel human checkpoint kinase gene, hCDS1, comprising the nucleic acid sequence of residues 66-1694 of SEQ ID NO: 1, a protein expressed from the gene, fragments and functional equivalents of the protein. The invention also provides for pharmaceutical compositions comprising a hCDS1 protein, and methods utilizing the protein.
    Type: Grant
    Filed: April 12, 2005
    Date of Patent: August 19, 2008
    Assignee: The Scripps Research Institute
    Inventors: Walter H. M. L. Luyten, Andrew E. Parker, Clare McGowan, Alessandra Blasina
  • Human checkpoint kinase, hCDS1, compositions and methods
    Patent number: 6943013
    Abstract: The invention provides for a novel human checkpoint kinase gene, hCDS1, translated protein, compositions, methods, and kits.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: September 13, 2005
    Assignee: The Scripps Research Institute
    Inventors: Walter H. M. L. Luyten, Andrew E. Parker, Clare McGowan, Alessandra Blasina
  • Polynucleotide encoding hCDS1, a human cell-cycle checkpoint kinase
    Patent number: 6531312
    Abstract: The invention provides for a novel human checkpoint kinase gene, hCDS1, translated protein, compositions, methods, and kits.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: March 11, 2003
    Assignee: Janssen Pharmaceutica
    Inventors: Walter H. M. L. Luyten, Andrew E. Parker
  • Human checkpoint kinase, hCDS1, compositions and methods
    Publication number: 20030017160
    Abstract: The invention provides for a novel human checkpoint kinase gene, hCDS1, translated protein, compositions, methods, and kits.
    Type: Application
    Filed: June 27, 2002
    Publication date: January 23, 2003
    Applicant: The Scripps Research Institute
    Inventors: Walter H.M.L. Luyten, Andrew E. Parker, Clare H. McGowan, Alessandra Blasina
  • Human checkpoint kinase, HCDS1, compositions and methods
    Patent number: 6413755
    Abstract: The invention provides for a novel human checkpoint kinase gene, hCDS 1, translated protein, compositions, methods, and kits.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: July 2, 2002
    Assignee: The Scripps Research Institute
    Inventors: Walter H. M. L. Luyten, Andrew E. Parker, Clare McGowan, Alessandra Blasina
  • Device for opening ampoules
    Patent number: 4506817
    Abstract: A device for opening ampoules comprises a hollow cylindrical body, the peripheral wall of which has slits forming two halves which can flex relatively apart or together at an open end of said body to enable entry of an ampoule head portion and for ejection of a broken head portion respectively. The body is dimensioned to accommodate an ampoule head and an inwardly-directed annular bead is provided at the open end against which the neck of an ampoule can be broken. A cutter protrudes from the bead. The bead is provided at the convergence of an outwardly-directed peripheral flange and an inwardly-directed annular ramp. A plunger whose piston is hollow is provided in the body to eject broken ampoule heads.
    Type: Grant
    Filed: December 20, 1982
    Date of Patent: March 26, 1985
    Inventor: Andrew E. Parker